Trial Profile
A large international, multi-center, prospective, cohort observational study to understand the incidence and clinical impact of chemotherapy-induced diarrhea in colorectal and breast cancer patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2015
Price :
$35
*
At a glance
- Drugs Elsiglutide (Primary)
- Indications Diarrhoea
- Focus Adverse reactions
- 09 Feb 2015 New trial record